Naim Alkhouri, MD, FAASLD

Chief Medical Officer, Director, Fatty Liver Program, and Chief of Transplant Hepatology

Naim Alkhouri, M.D., is the Chief Medical Officer (CMO), Chief of Transplant Hepatology, and Director of the Steatotic Liver Program at Arizona Liver Health (ALH) in Phoenix, AZ.
Dr. Alkhouri is a key opinion leader in the field of liver disease therapeutics and an advisor/ consultant to many pharmaceutical and biomarker development companies. He is Principal Investigator on several multicenter global MASH trials and a member of the AASLD MASLD Special Interest Group (MASLD SIG).
Dr. Alkhouri has been published in over 250 publications to include publications in the New England Journal of Medicine, Lancet, JAMA, and Nature Medicine.